AstraZeneca's MedImmune has received Food and Drug Administration approval for FluMist, an influenza vaccine that can be administered either by oneself or by a healthcare provider.

Artificial intelligence (AI) has the power to strengthen our economy, boost productivity, and create exciting new opportunities for every generation, including Millennials and Gen Z. The global race ...

In an email to The Post this week, a Boar’s Head spokesperson said, “We do not currently have any plans to reopen this plant.

Erin Nawrocki, a postdoctoral scholar in the Dudley Lab at Penn State and coauthor on the study, prepares samples to search for Salmonella in sewage. This work is supported by the Food and Drug ...

Zevra Therapeutics has won Food and Drug Administration approval of Miplyffa for Niemann-Pick disease type C, or NPC, making it the first drug cleared in the U.S. for the rare neurodegenerative ...

FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...

“Olympus’ continued failure to meet FDA requirements demonstrates a troubling disregard for patient safety,” said Jeffrey ...

Zevra Therapeutics has won Food and Drug Administration approval of Miplyffa for Niemann-Pick disease type C, or NPC, making it the first drug cleared in the U.S. for the rare neurodegenerative ...

First Off, What Did the FDA and Consumer Reports Find? In March and July, the FDA issued public alerts for brands of cinnamon ...

Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.

The snacks now have a Class I risk level, meaning there is a "reasonable probability" they could cause "serious adverse ...

The agency reviewed data from the MARIPOSA-2 trial and approved the regimen for patients with common EGFR mutations who are progressing on EGFR inhibitors.